CG Oncology (CGON) Capital Expenditures (2024 - 2026)
CG Oncology's (CGON) quarterly Capital Expenditures came in at $304000.0 in Q1 2026, up 1800.0% YoY from $16000.0 in Q1 2025, and up 4242.86% on a QoQ basis from $7000.0 in Q4 2025.
CG Oncology (CGON) Capital Expenditures (2024 - 2026) Analysis & Trends
CG Oncology (CGON) has 3 years of Capital Expenditures data on file, last reported at $304000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 1800.0% year-over-year to $304000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $422000.0 (up 77.31% YoY) and the FY2025 annual result came in at $134000.0, down 42.74% from the prior year.
- Capital Expenditures rose to $304000.0 in Q1 2026, from $7000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $304000.0 in Q1 2026 to a low of -$1000.0 in Q3 2024.
- A 3-year average of $74666.7 and a median of $14000.0 in 2024 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 9800.0% in 2025, down 96.65% in 2025.
- Tracing CGON's Capital Expenditures over 3 years: stood at $209000.0 in 2024, then tumbled by 96.65% to $7000.0 in 2025, then jumped by 4242.86% to $304000.0 in 2026.
- The last three Capital Expenditures figures came in at $304000.0 (Q1 2026), $7000.0 (Q4 2025), and $97000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | 468,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 468,000.00 |
| Jun 30, 2026 | 468,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |